Animal Models of Multiple Sclerosis: the Good, the Bad and the Bottom Line

Overview

Journal Nat Neurosci

Date 2012 Jul 28

PMID 22837037

Citations 170

Authors

Richard M Ransohoff

Affiliations

Soon will be listed here.

Abstract

Multiple sclerosis (MS) is a spontaneous, acquired, inflammatory demyelinating disease of the human CNS. Because it involves a complex interaction between two of the most intricate biological systems, immune system and CNS, animal modeling has been critical for addressing MS pathogenesis. MS models were originally developed serendipitously more than 75 years ago. Immune-mediated, toxic, viral and genetic models of demyelination are now used to understand the manifold aspects of MS. MS treatments evolved in part from animal model research, and further progress is envisaged in large part because these systems have been continually refined and their use focused on questions whose relevance was established by studying the human disease.

Citing Articles

Adapting systems biology to address the complexity of human disease in the single-cell era.

Fischer D, Villanueva M, Winter P, Shalek A Nat Rev Genet. 2025; .

PMID: 40065155 DOI: 10.1038/s41576-025-00821-6.

Cathelicidin antimicrobial peptide expression in neutrophils and neurons antagonistically modulates neuroinflammation.

Verma S, Enee E, Manasse K, Rebhi F, Penc A, Romeo-Guitart D J Clin Invest. 2024; 135(3).

PMID: 39656548 PMC: 11785927. DOI: 10.1172/JCI184502.

Stearoyl-CoA desaturase-1: a potential therapeutic target for neurological disorders.

Loix M, Vanherle S, Turri M, Kemp S, Fernandes K, Hendriks J Mol Neurodegener. 2024; 19(1):85.

PMID: 39563397 PMC: 11575020. DOI: 10.1186/s13024-024-00778-w.

A diet-dependent host metabolite shapes the gut microbiota to protect from autoimmunity.

Alexander M, Upadhyay V, Rock R, Ramirez L, Trepka K, Puchalska P Cell Rep. 2024; 43(11):114891.

PMID: 39500329 PMC: 11660937. DOI: 10.1016/j.celrep.2024.114891.

25-hydroxycholesterol promotes brain cytokine production and leukocyte infiltration in a mouse model of lipopolysaccharide-induced neuroinflammation.

Romero J, Toral-Rios D, Yu J, Paul S, Cashikar A J Neuroinflammation. 2024; 21(1):251.

PMID: 39369253 PMC: 11456242. DOI: 10.1186/s12974-024-03233-1.

References

Ransohoff R . A mighty mouse: building a better model of multiple sclerosis. J Clin Invest. 2006; 116(9):2313-6. PMC: 1555651. DOI: 10.1172/JCI29834. View

Lipton H . Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun. 1975; 11(5):1147-55. PMC: 415190. DOI: 10.1128/iai.11.5.1147-1155.1975. View

Waksman B, Adams R . A histologic study of the early lesion in experimental allergic encephalomyelitis in the guinea pig and rabbit. Am J Pathol. 1962; 41:135-62. PMC: 1949599. View

Trapp B, Peterson J, Ransohoff R, Rudick R, Mork S, Bo L . Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998; 338(5):278-85. DOI: 10.1056/NEJM199801293380502. View

Uccelli A, Giunti D, Capello E, Roccatagliata L, Mancardi G . EAE in the common marmoset Callithrix jacchus. Int MS J. 2003; 10(1):6-12. View

Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H . Remyelination is extensive in a subset of multiple sclerosis patients. Brain. 2006; 129(Pt 12):3165-72. DOI: 10.1093/brain/awl217. View

Ludwin S . Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Lab Invest. 1978; 39(6):597-612. View

Sawcer S, Hellenthal G, Pirinen M, Spencer C, Patsopoulos N, Moutsianas L . Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011; 476(7359):214-9. PMC: 3182531. DOI: 10.1038/nature10251. View

Pohl H, Porcheri C, Mueggler T, Bachmann L, Martino G, Riethmacher D . Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J Neurosci. 2011; 31(3):1069-80. PMC: 6632929. DOI: 10.1523/JNEUROSCI.5035-10.2011. View

10.

Yasuda T, TSUMITA T, Nagai Y, Mitsuzawa E, Ohtani S . Experimental allergic encephalomyelitis (EAE) in mice. I. Induction of EAE with mouse spinal cord homogenate and myelin basic protein. Jpn J Exp Med. 1975; 45(5):423-7. View

11.

Bergmann C, Lane T, Stohlman S . Coronavirus infection of the central nervous system: host-virus stand-off. Nat Rev Microbiol. 2006; 4(2):121-32. PMC: 7096820. DOI: 10.1038/nrmicro1343. View

12.

Waksman B . Demyelinating disease: evolution of a paradigm. Neurochem Res. 1999; 24(4):491-5. DOI: 10.1023/a:1022527628192. View

13.

Arnett H, Mason J, Marino M, Suzuki K, Matsushima G, Ting J . TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci. 2001; 4(11):1116-22. DOI: 10.1038/nn738. View

14.

Dal Canto M, Melvold R, Kim B, Miller S . Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Microsc Res Tech. 1995; 32(3):215-29. PMC: 7166956. DOI: 10.1002/jemt.1070320305. View

15.

Huseby E, Liggitt D, Brabb T, Schnabel B, Ohlen C, Goverman J . A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med. 2001; 194(5):669-76. PMC: 2195947. DOI: 10.1084/jem.194.5.669. View

16.

Ferguson B, Matyszak M, Esiri M, Perry V . Axonal damage in acute multiple sclerosis lesions. Brain. 1997; 120 ( Pt 3):393-9. DOI: 10.1093/brain/120.3.393. View

17.

Berer K, Wekerle H, Krishnamoorthy G . B cells in spontaneous autoimmune diseases of the central nervous system. Mol Immunol. 2010; 48(11):1332-7. DOI: 10.1016/j.molimm.2010.10.025. View

18.

Skripuletz T, Gudi V, Hackstette D, Stangel M . De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected. Histol Histopathol. 2011; 26(12):1585-97. DOI: 10.14670/HH-26.1585. View

19.

Ascherio A, Munger K . Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol. 2007; 61(6):504-13. DOI: 10.1002/ana.21141. View

20.

Blakemore W, Franklin R . Remyelination in experimental models of toxin-induced demyelination. Curr Top Microbiol Immunol. 2008; 318:193-212. DOI: 10.1007/978-3-540-73677-6_8. View